NeuroSense Therapeutics Ltd. (NRSNW) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $166.0K | -95.1% |
| 2024 | $3.38M | +28.0% |
| 2023 | $2.64M | -25.5% |
| 2022 | $3.54M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $166.0K | -95.1% |
| 2024 | $3.38M | +28.0% |
| 2023 | $2.64M | -25.5% |
| 2022 | $3.54M | — |